IGFIR Over-Expression and Breast Cancer Progression
Author Information
Author(s): Gina M Yanochko, Walter Eckhart
Primary Institution: The Salk Institute for Biological Studies
Hypothesis
How does the activation of the type I insulin-like growth factor receptor (IGFIR) affect breast epithelial cell biology and contribute to breast cancer progression?
Conclusion
Increased proliferation and survival signaling due to IGFIR activation in mammary epithelial cells may promote early lesions of breast cancer.
Supporting Evidence
- MCF-10A cells over-expressing IGFIR formed large, misshapen acinar structures.
- Inhibition of PI3K or MEK prevented acinar structure development in IGFIR-expressing cells.
- IGFIR structures displayed increased proliferation and decreased apoptosis compared to control structures.
Takeaway
When certain cells in the breast have too much of a specific growth signal, they can grow too much and not die when they should, which might lead to cancer.
Methodology
MCF-10A breast epithelial cells were modified to express wild-type or kinase-dead IGFIR, and their effects on cell biology were analyzed in three-dimensional cultures.
Limitations
The study primarily uses a single cell line, which may limit the generalizability of the findings.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website